Page last updated: 2024-10-30

leflunomide and Respiratory Tract Infections

leflunomide has been researched along with Respiratory Tract Infections in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.

Research Excerpts

ExcerptRelevanceReference
"Treatment of rheumatoid arthritis (RA) has changed with the release of more efficient disease-modifying anti-inflammatory drugs (DMARDs) and biologicals, such as methotrexate, leflunomide and TNF blockers, respectively."4.82[Respiratory complications of new treatments for rheumatoid arthritis]. ( Lioté, H, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cano-Jiménez, E1
Vázquez Rodríguez, T1
Martín-Robles, I1
Castillo Villegas, D1
Juan García, J1
Bollo de Miguel, E1
Robles-Pérez, A1
Ferrer Galván, M1
Mouronte Roibas, C1
Herrera Lara, S1
Bermudo, G1
García Moyano, M1
Rodríguez Portal, JA1
Sellarés Torres, J1
Narváez, J1
Molina-Molina, M1
Lioté, H1

Reviews

1 review available for leflunomide and Respiratory Tract Infections

ArticleYear
[Respiratory complications of new treatments for rheumatoid arthritis].
    Revue des maladies respiratoires, 2004, Volume: 21, Issue:6 Pt 1

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide; Lung Diseases; Methotr

2004

Other Studies

1 other study available for leflunomide and Respiratory Tract Infections

ArticleYear
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis.
    Scientific reports, 2021, 04-28, Volume: 11, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Sectional Studies

2021